Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 203284
Company: HORIZON THERAP US
Company: HORIZON THERAP US
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
RAVICTI | GLYCEROL PHENYLBUTYRATE | 1.1GM/ML | LIQUID;ORAL | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
02/01/2013 | ORIG-1 | Approval | Type 2 - New Active Ingredient | STANDARD; Orphan |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203284s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/203284Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/203284Orig1s000TOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
09/03/2021 | SUPPL-12 | Labeling-Package Insert, Labeling-Medication Guide |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203284Orig1s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/203284Orig1s012ltr.pdf | |
10/04/2019 | SUPPL-11 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203284s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/203284Orig1s011ltr.pdf | |
12/21/2018 | SUPPL-10 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/203284s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/203284Orig1s010Ltr.pdf | |
04/28/2017 | SUPPL-5 | Efficacy-New Patient Population |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203284s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/203284Orig1s005ltr.pdf | |
09/08/2016 | SUPPL-4 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203284s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/203284Orig1s004ltr.pdf | |
07/27/2015 | SUPPL-3 | Manufacturing (CMC) |
Label is not available on this site. |
||
01/05/2015 | SUPPL-2 | Manufacturing (CMC) |
Label is not available on this site. |
||
06/24/2014 | SUPPL-1 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203284s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/203284Orig1s001ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
09/03/2021 | SUPPL-12 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203284Orig1s012lbl.pdf | |
09/03/2021 | SUPPL-12 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/203284Orig1s012lbl.pdf | |
10/04/2019 | SUPPL-11 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203284s011lbl.pdf | |
12/21/2018 | SUPPL-10 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/203284s010lbl.pdf | |
04/28/2017 | SUPPL-5 | Efficacy-New Patient Population | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203284s005lbl.pdf | |
09/08/2016 | SUPPL-4 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/203284s004lbl.pdf | |
06/24/2014 | SUPPL-1 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/203284s001lbl.pdf | |
02/01/2013 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203284s000lbl.pdf |